The cost effectiveness of Nucleic Acid Amplification Techniques for the diagnosis of tuberculosis

Respiratory Medicine

Volumn 106, Issue 2, 2012, Pages 300-307

  Hughes, Ralph ^a   Wonderling, David ^b   Li, Bernadette ^c   Higgins, Bernard ^a  

^a Centre for Acute and Chronic Conditions   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Diagnostic techniques; Health economics; Polymerase chain reaction; Respiratory infection; Tuberculosis

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DELAYED DIAGNOSIS; DRUG COST; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEALTH SERVICE; HUMAN; NUCLEIC ACID AMPLIFICATION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; TUBERCULOSIS; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; DECISION TREES; DIRECT SERVICE COSTS; FEMALE; GREAT BRITAIN; HUMANS; MALE; MICROSCOPY; NATIONAL HEALTH PROGRAMS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 84655175129     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.10.005     Document Type: Article

References (33)

1. Health Protection Agency Centre for Infections Tuberculosis in the UK: annual report on tuberculosis surveillance in the UK 2009 2009 Health Protection Agency London
2. New diagnostics working group of the Stop TB Partnership Pathways to better diagnostics for tuberculosis: a blueprint for the development of TB diagnostics 2009 World Health Organization Geneva
3. P.D. Davies, and M. Pai The diagnosis and misdiagnosis of tuberculosis Int J Tuberc Lung Dis 12 11 2008 Nov 1226 1234
4. J. Dinnes, J. Deeks, H. Kunst, A. Gibson, E. Cummins, and N. Waugh A systematic review of rapid diagnostic tests for the detection of tuberculosis infection Health Technol Assess 11 3 2007 Jan 1 196
5. D.I. Ling, L.L. Flores, L.W. Riley, and M. Pai Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression PLoS One 3 2 2008 e1536
6. S. Greco, E. Girardi, A. Navarra, and C. Saltini Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis Thorax 61 9 2006 Sep 783 790 (Pubitemid 44369403)
7. National Collaborating Centre for Chronic Conditions Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control 2006 Royal College of Physicians London
8. World Health Organization Treatment of Tuberculosis: guidelines for national programmes Geneva. Report No. 4th ed. 2010
9. S. Paynter, A. Hayward, P. Wilkinson, S. Lozewicz, and R. Coker Patient and health service delays in initiating treatment for patients with pulmonary tuberculosis: retrospective cohort study Int J Tuberc Lung Dis 8 2 2004 Feb 180 185 (Pubitemid 38622925)
10. K.R. Steingart, M. Henry, V. Ng, P.C. Hopewell, A. Ramsay, and J. Cunningham Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review Lancet Infect Dis 6 9 2006 Sep 570 581 (Pubitemid 44262344)
11. Stop TB Partnership's New Diagnostics working Group. Evidence-based tuberculosis diagnosis. http://wwwtbevidenceorg/ 2010 July 25Available from: URL: http://www.tbevidence.org/.
12. Center for the Evaluation of Value and Risk in Health. Cost-effectiveness analysis registry. https://researchtufts-nemcorg/cear/Defaultaspx 2010Available from: URL: https://research.tufts-nemc.org/cear/Default.aspx.
13. H. Gelband Regimens of less than six months for treating tuberculosis Cochrane Database Syst Rev 2 2000 CD001362
14. Stop TB Partnership Frequently asked questions about the 4-drug fixed-dose combination tablet recommended by the World Health Organization for treating tuberculosis 2002 World Health Organization Geneva
15. E. Nathanson, R. Gupta, P. Huamani, V. Leimane, A.D. Pasechnikov, and T.E. Tupasi Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative Int J Tuberc Lung Dis 8 11 2004 Nov 1382 1384 (Pubitemid 39611587)
16. T. Frieden Toman's tuberculosis case detection, treatment, and monitoring: questions and answers vol. 2 2004 World Health Organisation Geneva
17. P. Kind, S. Macran, and G. Hardman UK population norms for EQ-5D 1999
18. M.C. Tan, C.A. Marra, M. Sadatsafavi, F. Marra, O. Moran-Mendoza, and S. Moadebi Cost-effectiveness of LTBI treatment for TB contacts in British Columbia Value Health 11 5 2008 Sep 842 852
19. K. Khan, P. Muennig, M. Behta, and J.G. Zivin Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States N Engl J Med 347 23 2002 Dec 5 1850 1859 (Pubitemid 35417777)
20. D.P. Holland, G.D. Sanders, C.D. Hamilton, and J.E. Stout Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection Am J Respir Crit Care Med 179 11 2009 Jun 1 1055 1060
21. D.W. Dowdy, M.A. O'Brien, and D. Bishai Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis Int J Tuberc Lung Dis 12 9 2008 Sep 1021 1029
22. M.A. Behr, S.A. Warren, H. Salamon, P.C. Hopewell, A.P. de Leon, and C.L. Daley Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli The Lancet 353 9151 1999 Feb 6 444 449 (Pubitemid 29067335)
23. CCEMG - EPPI-Centre Cost Converter' (v.1.0). http://eppiioeacuk/ costconversion/defaultaspx2010 2010 January [cited 2010 Aug 9];Available from: URL: http://eppi.ioe.ac.uk/costconversion/default.aspx.
24. BNF - 59 British Medical Association and Royal Pharmaceutical Socie 2010 British Medical Journal Group and the Pharmaceutical Press [British National Formulary]
25. V.L. White, and J. Moore-Gillon Resource implications of patients with multidrug resistant tuberculosis Thorax 55 11 2000 Nov 962 963
26. Department of Health. Payment by Results National Tariff 2008/09. http://collectionseuroparchiveorg/tna/20100509080731/http://dhgovuk/en/ Managingyourorganisation/Financeandplanning/NHSFinancialReforms/DH-0812382010 June 4 [cited 2010 Aug 11]
27. I. Rajalahti, E.L. Ruokonen, T. Kotomaki, H. Sintonen, and M.M. Nieminen Economic evaluation of the use of PCR assay in diagnosing pulmonary TB in a low-incidence area Eur Respir J 23 3 2004 Mar 446 451 (Pubitemid 38344384)
28. O.L. Sarmiento, K.A. Weigle, J. Alexander, D.J. Weber, and W.C. Miller Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis J Clin Microbiol 41 7 2003 Jul 3233 3240 (Pubitemid 36842327)
29. D.W. Dowdy, A. Maters, N. Parrish, C. Beyrer, and S.E. Dorman Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens J Clin Microbiol 41 3 2003 Mar 948 953 (Pubitemid 36307091)
30. B.R. Roos, M.R. van Cleeff, W.A. Githui, L. Kivihya-Ndugga, J.A. Odhiambo, and D.K. Kibuga Cost-effectiveness of the polymerase chain reaction versus smear examination for the diagnosis of tuberculosis in Kenya: a theoretical model Int J Tuberc Lung Dis 2 3 1998 Mar 235 241 (Pubitemid 28123524)
31. J. Whitehorn, H. Ayles, and P. Godfrey-Faussett Extra-pulmonary and smear-negative forms of tuberculosis are associated with treatment delay and hospitalisation Int J Tuberc Lung Dis 14 6 2010 Jun 741 744
32. A.M. Rose, J.M. Watson, C. Graham, A.J. Nunn, F. Drobniewski, and L.P. Ormerod Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998 Thorax 56 3 2001 Mar 173 179
33. V.L.C. White, M. Paliwalla, C.J. Steves, D. Jadhav, and J. Moore-Gillon Management of tuberculosis in a British inner-city population J Public Health 24 1 2002 Mar 1 49 52 (Pubitemid 34245591)